Klingman & Associates’s Blend Labs BLND Stock Holding History

Klingman & Associates’s Portfolio BLND Stock Details BLND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-237,000	Closed	-$341K	–	200
2022 Q4	$341K	Buy	+237,000	New	+$425K	0.03%	146

Other funds holding BLND

General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

LUGPI

Lightspeed Ultimate General Partner IX Menlo Park, California $20.3M AUM 4.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

ShawSpring Partners Boston, Massachusetts $268M AUM 28.19% 1-Year Est. Return

Greylock 15 Menlo Park, California $85.6M AUM 199.44% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Klingman & Associates's BLND Position: Q1 2023 in Review

Klingman & Associates sold out of Blend Labs (BLND) in Q1 2023, closing a stake of 237,000 shares — an estimated $341K sold.

Klingman & Associates first reported a position in BLND in Q4 2022 and held it in 1 quarter. The position peaked at $341K in Q4 2022. 111 funds tracked by Wall St. Rank hold BLND as of Q1 2023.

Klingman & Associates reported no remaining Blend Labs position as of Q1 2023 after selling out during the quarter.
Klingman & Associates sold 237,000 Blend Labs shares in Q1 2023, an estimated $341K.
Klingman & Associates first reported a position in Blend Labs in Q4 2022 and held it in 1 quarter.
Klingman & Associates's Blend Labs position peaked at $341K in Q4 2022.
111 funds tracked by Wall St. Rank held Blend Labs as of Q1 2023.

Based on Klingman & Associates's 13F filing for Q1 2023, filed 3 May 2023.